Pharmaceutica Analytica Acta

A review of advances in injectable drugs and devices

5^th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems

March 16-18, 2015 Crowne Plaza, Dubai, UAE

Pankaj Sharma

Posters & Accepted Abstracts: Pharm Anal Acta

Abstract:

Recent advancements in coatings, mechanisms and device designs have led to prefilled biological in patient-friendly drugdevice combination products that were not that much reliable and possible few years ago. Latest prefilled drug cartridges had made it easier to use and have reduced the cost of injectable pens and auto injectors, making them accessible to a larger segment of the chronically ill patients. Injectors with advanced features such as variable dosing, dose counters and audible cues are making self-administration safer for patients prescribed immune modulators with black box warnings. To streamline the drug-device development process, drug developers are increasingly aligning themselves with device suppliers, increasing the level of concurrent engineering, identifying design challenges earlier and minimizing possible delays that could result. This trend represents risks for injecting drug firms competing for device solutions for their sophisticated formulations. It is also an opportunity for smaller device suppliers who are able to demonstrate the financial and technological resources to address the needs of injectable drug developers.